Pamela Vo
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: August 01, 2023
Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection.
Journal: Multiple sclerosis and related disorders
Published: April 14, 2023
Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey.
Journal: Current medical research and opinion
Published: March 15, 2023
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
Journal: Headache
Published: January 27, 2023
Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.
Journal: Current medical research and opinion
Published: October 03, 2022
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.
Journal: Journal of medical economics
Published: July 27, 2021
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: May 17, 2021
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey.
Journal: Journal of medical economics
Published: May 06, 2021
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.
Journal: The journal of headache and pain
Published: February 16, 2021
Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden.
Journal: PharmacoEconomics
Published: December 24, 2020
Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments.
Journal: Neurology. Clinical practice
Published: November 20, 2020
Economic evaluations in migraine: systematic literature review and a novel approach.
Journal: Journal of medical economics
Published: April 15, 2020
Last Updated: 09/26/2026